| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/25/2005 | EP1531842A2 Regulation of cell growth by muc1 |
| 05/25/2005 | EP1531830A1 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations |
| 05/25/2005 | EP1531824A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 05/25/2005 | EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors |
| 05/25/2005 | EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 05/25/2005 | EP1531808A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 05/25/2005 | EP1531806A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 05/25/2005 | EP1531804A1 Method of inhibiting angiogenesis |
| 05/25/2005 | EP1531803A1 Method of inhibiting prostate cancer cell proliferation |
| 05/25/2005 | EP1531800A2 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 05/25/2005 | EP1531716A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 05/25/2005 | EP1438390A4 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 05/25/2005 | EP1372670B1 Caloporoside derivatives, methods for the production thereof and their use |
| 05/25/2005 | EP1365762A4 Method for increasing leptin levels using nicotinic acid compounds |
| 05/25/2005 | EP1341791B1 Thioether substituted imidazoquinolines |
| 05/25/2005 | EP1322286B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 05/25/2005 | EP1307594A4 Association of sim2 with cancer |
| 05/25/2005 | EP1287137B1 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | EP1279039A4 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 05/25/2005 | EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 05/25/2005 | EP1165106B1 Composition and method for inducing apoptosis in prostate cancer cells by m-dna and mcc |
| 05/25/2005 | EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
| 05/25/2005 | EP0994903B1 Methods and compositions for galactosylated glycoproteins |
| 05/25/2005 | EP0966304B1 Site-specific drug delivery |
| 05/25/2005 | EP0907370B1 Hla-a2.1 binding peptides and their uses |
| 05/25/2005 | EP0904274B1 Farnesyl transferase inhibitors |
| 05/25/2005 | EP0871702B1 Cytokine designated lerk-7 |
| 05/25/2005 | EP0813419B1 Modulators of regulatory proteins |
| 05/25/2005 | EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles |
| 05/25/2005 | CN1620510A Cytokine protein family |
| 05/25/2005 | CN1620500A Corona-virus-like particles comprising functionally deleted genomes |
| 05/25/2005 | CN1620468A Novel anti-igf-ir antibodies and uses thereof |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620466A Cystine-knot fold protein |
| 05/25/2005 | CN1620464A Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors |
| 05/25/2005 | CN1620458A 噻吩并嘧啶 Thienopyrimidine |
| 05/25/2005 | CN1620457A Tetracyclic heterocompounds as estrogen receptor modulators |
| 05/25/2005 | CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 05/25/2005 | CN1620451A Benzhydryl derivatives |
| 05/25/2005 | CN1620448A Piperidine-2, 6-diones heterocyclically substituted in the 3-position |
| 05/25/2005 | CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1620431A (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620314A Gas micro-liposome compound |
| 05/25/2005 | CN1620313A Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 05/25/2005 | CN1620311A Therapeutic agent |
| 05/25/2005 | CN1620309A Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| 05/25/2005 | CN1620305A Method of inducing apoptosis and compositions therefor |
| 05/25/2005 | CN1620299A Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 05/25/2005 | CN1620296A Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 05/25/2005 | CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 05/25/2005 | CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors |
| 05/25/2005 | CN1620289A Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 05/25/2005 | CN1620285A Novel microsphere and method for production thereof |
| 05/25/2005 | CN1620283A Dispersions for formulating slightly or poorly soluble active ingredients |
| 05/25/2005 | CN1618978A Configuration of cell facter IL-24 eucargon expression carrier and application |
| 05/25/2005 | CN1618969A Mammalian sytokine-like polypeptide-10 |
| 05/25/2005 | CN1618946A Cancer prevention health protection fermented wine |
| 05/25/2005 | CN1618810A New mastocancer related protein and its specificity multiclone antibody |
| 05/25/2005 | CN1618809A New mastocancer related protein and its specificity multiclone antibody |
| 05/25/2005 | CN1618803A Recombinated phycobiliprotein and its preparation method and application |
| 05/25/2005 | CN1618465A 联合疫苗组合物 Combined vaccine composition |
| 05/25/2005 | CN1618459A Translation initiation factor eIF-5A and medical application of it and syntenin complex |
| 05/25/2005 | CN1618447A Traditional Chinese medicine prescription for treating tumour, prepn. process use thereof |
| 05/25/2005 | CN1618425A Composition contg. theaflavin and its derivatives, prepn. method and application thereof |
| 05/25/2005 | CN1203090C Cyclic bonding inhibitor |
| 05/25/2005 | CN1203074C Pentacycle taxane compounds |
| 05/25/2005 | CN1203071C Polysaccharidic esters of N-derivatives of glutamic acid |
| 05/25/2005 | CN1203070C Thrombin receptor antagonists |
| 05/25/2005 | CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 05/25/2005 | CN1203055C Method and composition for treating or preventing bacterial infection |
| 05/25/2005 | CN1202836C Toad skin preparation and productive process thereof |
| 05/25/2005 | CN1202828C Use of diphosphonic acid in preparing medicine for treatment of vasculogenesis |
| 05/25/2005 | CN1202817C Solid disperser of quick-releasing vitamine A acid |
| 05/25/2005 | CA2448831A1 Multi-stage cascade boosting vaccine |
| 05/24/2005 | US6897319 Therapeutic drugs for treating central nervous system disorders |
| 05/24/2005 | US6897318 Process for making substituted pyrazoles |
| 05/24/2005 | US6897316 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents |
| 05/24/2005 | US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2005 | US6897235 Compositions useful for the treatment of pathologies responding to the activation of PPAR-γ receptor |
| 05/24/2005 | US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole |
| 05/24/2005 | US6897223 Nitrogen compounds such as Benzyl-8-methyl-5,7-dioxo-1,5,6,7-tetrahydro-(1,2,4)triazolo(1,5-a)pyridine -2-carboxylic acid benzylamide, used for prophylaxis of arthritis, inflammation or cancer |
| 05/24/2005 | US6897221 Urea substituted imidazoquinolines |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/24/2005 | US6897218 Nitric oxide donors based on metallic centers |
| 05/24/2005 | US6897214 Quinazoline derivatives |
| 05/24/2005 | US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 05/24/2005 | US6897210 Anticancer agents; antiarthritic agents |
| 05/24/2005 | US6897209 Thrombosis; anticholesterol agents; cardiovascular disorders; antiinflammatory agents; anticancer agents |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6897203 Polysaccharidic esters of retinoic acid |
| 05/24/2005 | US6897054 For controlling in vitro cell proliferation; genetic engineering |
| 05/24/2005 | US6897050 Desaturase genes and their use |
| 05/24/2005 | US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters |
| 05/24/2005 | US6897034 Antitumor agents; drug immobilized to oligopeptide; complexing; testing, calibration of complex to see if capable of being split enzyme; drug design |
| 05/24/2005 | US6896907 Use of bioactive fraction from cow urine distillate (‘go-mutra’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 05/24/2005 | US6896885 Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |